UNI-EN 90:Current report 90 re insiders transactions
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| | UNI - EN REPORT No | 90 | / | 2012 | | ||||||
| Date of issue: | 2012-09-18 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Current report 90 re insiders transactions | |||||||||||
| Official market - legal basis | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| The Board of Directors of Sopharma AD (the “Company") announces that it was notified by Mr. Ognian Donev, Chairman of the Board of Directors that the company “Donev Investments Holding AD" related to him, executed the following transactions related to shares in the Company: Date and time of the settlement Operation Number of shares Unit price (BGN) 11.09.2012 Buy 1000 2.401 11.09.2012 Buy 5000 2.405 11.09.2012 Buy 3000 2.400 11.09.2012 Buy 3000 2.400 11.09.2012 Buy 1100 2.400 10.09.2012 Sale 605 2.455 10.09.2012 Sale 155 2.455 10.09.2012 Sale 125 2.455 10.09.2012 Sale 118 2.455 11.09.2012 Sale 300 2.449 11.09.2012 Sale 200 2.440 12.09.2012 Sale 165 2.438 12.09.2012 Sale 57 2.438 The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Current report 90 re insiders transactions.doc Current report 90 re insiders transactions.doc | Current report 90 re insiders transactions | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2012-09-18 | Ognian Donev | Executive Director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to None PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
